Search Results - "Gale, Joanna"

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial by Parker, Chris C, James, Nicholas D, Brawley, Christopher D, Clarke, Noel W, Ali, Adnan, Amos, Claire L, Attard, Gerhardt, Chowdhury, Simon, Cook, Adrian, Cross, William, Dearnaley, David P, Douis, Hassan, Gilbert, Duncan C, Gilson, Clare, Gillessen, Silke, Hoyle, Alex, Jones, Rob J, Langley, Ruth E, Malik, Zafar I, Mason, Malcolm D, Matheson, David, Millman, Robin, Rauchenberger, Mary, Rush, Hannah, Russell, J Martin, Sweeney, Hannah, Bahl, Amit, Birtle, Alison, Capaldi, Lisa, Din, Omar, Ford, Daniel, Gale, Joanna, Henry, Ann, Hoskin, Peter, Kagzi, Mohammed, Lydon, Anna, O'Sullivan, Joe M, Paisey, Sangeeta A, Parikh, Omi, Pudney, Delia, Ramani, Vijay, Robson, Peter, Srihari, Narayanan Nair, Tanguay, Jacob, Parmar, Mahesh K B, Sydes, Matthew R

“…STAMPEDE has previously reported that radiotherapy (RT) to the prostate improved overall survival (OS) for patients with newly diagnosed prostate cancer with…”
Get full text

Prognostic factors and treatment choice for stage IV, low-volume metastasis hormone-sensitive prostate cancer: cross-sectional study of real-world data by Elewaily, Mohamed Ibrahim, Campione, Marina, Hassan, Mona Ali, Anpalakhan, Shobana, Atsumi, Naoko, Smalley, Benjamin, Ashraf, Anza, Gale, Joanna, Maniam, Akash, Banna, Giuseppe Luigi

“…Background: Many metastatic prostate cancer prognostics have been suggested, but few are validated. Nodal metastasis burden and baseline biochemical…”
Get full text

Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center by GALE, J, SIMMONDS, P. D, MEAD, G. M, SWEETENHAM, J. W, WRIGHT, D. H

“…We report the clinical features and treatment of 31 patients with a diagnosis of enteropathy-type intestinal T-cell lymphoma treated at the Wessex Regional…”
Get full text

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol by Attard, Gerhardt, Murphy, Laura, Clarke, Noel W, Jones, Robert J, Cook, Adrian, Brawley, Chris, Amos, Claire L, Atako, Nafisah, Chowdhury, Simon, Russell, J Martin, Gilson, Clare, Rush, Hannah, Bowen, Jo, O'Sullivan, Joe M, Birtle, Alison, Gale, Joanna, Srihari, Narayanan, Tanguay, Jacob, Gray, Emma, Alzoueb, Mymoona, Parikh, Omi, Robinson, Angus, Syndikus, Isabel, Wylie, James, Thalmann, George, Dearnaley, David P, Mason, Malcolm D, Gilbert, Duncan, Sydes, Matthew R, Brown, Louise C, Parmar, Mahesh K B, Jones, Elin, Hyde, Katherine, Glen, Hilary, Needleman, Sarah, McGovern, Ursula, Sheehan, Denise, Paisey, Sangeeta, Shaffer, Richard, Beresford, Mark, Malik, Zafar, Zarkar, Anjali, Porfiri, Emilio, Brock, Sue, Bahl, Amit, Smith-Howell, Mike, Woodward, Cathryn, Phan, Mau-Don, Mazhar, Danish, Hamid, Abdel, Ibrahim, Azman, Muthukumar, Dakshinamoorthy, Worlding, Jane, Kagzi, Mohammed, Pezaro, Carmel, Keng-Koh, Pek, McLaren, Duncan, Gupta, Nishi, Boussios, Stergios, Taylor, Henry, Perna, Carla, Grant, Warren, Sabharwal, Ami, Hofmann, Uschi, Dealey, Robert, Brierly, Robert, Capaldi, Lisa, Vivekanandan, Sindu, Tipples, Karen, Afshar, Mehran, Brulinski, Patryk, Sangar, Vijay, Peedell, Clive, Mullassery, Viwod, Protheroe, Andrew, Tarver, Kathryn, Gibbs, Stephanie, Khan, Mohammad Muneeb, Hingorani, Mohan, Crabb, Simon, Bhalla, Neeraj, Logue, John, Leaning, Darren, Vengalil, Salil, Ford, Daniel, Walker, Georgina, Shaheen, Ahmed, Chan, Andrew, Ahmed, Imtiaz, Hilman, Serena, Sayers, Ian, Porter, Tim, Joseph, Joji, Rentsch, Cyrill, Roggero, Enrico, Beyer, Jörg, Strebel, Raeto, Engeler, Daniel, John, Hubert, Durr, Donat

“…Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation therapy (ADT) for 3 years, often combined with radiotherapy. We…”
Get full text

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial by Parker, Christopher C, James, Nicholas D, Brawley, Christopher D, Clarke, Noel W, Hoyle, Alex P, Ali, Adnan, Ritchie, Alastair W S, Attard, Gerhardt, Chowdhury, Simon, Cross, William, Dearnaley, David P, Gillessen, Silke, Gilson, Clare, Jones, Robert J, Langley, Ruth E, Malik, Zafar I, Mason, Malcolm D, Matheson, David, Millman, Robin, Russell, J Martin, Thalmann, George N, Amos, Claire L, Alonzi, Roberto, Bahl, Amit, Birtle, Alison, Din, Omar, Douis, Hassan, Eswar, Chinnamani, Gale, Joanna, Gannon, Melissa R, Jonnada, Sai, Khaksar, Sara, Lester, Jason F, O'Sullivan, Joe M, Parikh, Omi A, Pedley, Ian D, Pudney, Delia M, Sheehan, Denise J, Srihari, Narayanan Nair, Tran, Anna T H, Parmar, Mahesh K B, Sydes, Matthew R

“…Based on previous findings, we hypothesised that radiotherapy to the prostate would improve overall survival in men with metastatic prostate cancer, and that…”
Get full text

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy by James, Nicholas D, de Bono, Johann S, Spears, Melissa R, Clarke, Noel W, Mason, Malcolm D, Dearnaley, David P, Ritchie, Alastair W.S, Amos, Claire L, Gilson, Clare, Jones, Rob J, Matheson, David, Millman, Robin, Attard, Gerhardt, Chowdhury, Simon, Cross, William R, Gillessen, Silke, Parker, Christopher C, Russell, J. Martin, Berthold, Dominik R, Brawley, Chris, Adab, Fawzi, Aung, San, Birtle, Alison J, Bowen, Jo, Brock, Susannah, Chakraborti, Prabir, Ferguson, Catherine, Gale, Joanna, Gray, Emma, Hingorani, Mohan, Hoskin, Peter J, Lester, Jason F, Malik, Zafar I, McKinna, Fiona, McPhail, Neil, Money-Kyrle, Julian, O’Sullivan, Joe, Parikh, Omi, Protheroe, Andrew, Robinson, Angus, Srihari, Narayanan N, Thomas, Carys, Wagstaff, John, Wylie, James, Zarkar, Anjali, Parmar, Mahesh K.B, Sydes, Matthew R

“…The addition of abiraterone and prednisolone to standard androgen-deprivation therapy as the first treatment for patients with locally advanced or metastatic…”
Get full text

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial by James, Nicholas D, Prof, Sydes, Matthew R, MSc, Clarke, Noel W, Prof, Mason, Malcolm D, Prof, Dearnaley, David P, Prof, Spears, Melissa R, MSc, Ritchie, Alastair W S, MD, Parker, Christopher C, MD, Russell, J Martin, FRCR, Attard, Gerhardt, MD PhD, de Bono, Johann, Prof, Cross, William, PhD, Jones, Rob J, Prof, Thalmann, George, Prof, Amos, Claire, PhD, Matheson, David, PhD, Millman, Robin, Alzouebi, Mymoona, FRCR, Beesley, Sharon, FRCR, Birtle, Alison J, MD, Brock, Susannah, FRCR, Cathomas, Richard, MD, Chakraborti, Prabir, FRCR, Chowdhury, Simon, MD, Cook, Audrey, FRCR, Elliott, Tony, PhD, Gale, Joanna, DM, Gibbs, Stephanie, FRCR, Graham, John D, FRCP, Hetherington, John, FRCS[Eng], Hughes, Robert, FRCR, Laing, Robert, FRCR, McKinna, Fiona, FRCR, McLaren, Duncan B, FRCR, FRCP[Ed], O'Sullivan, Joe M, Prof, Parikh, Omi, FRCR, Peedell, Clive, FRCR, Protheroe, Andrew, PhD, Robinson, Angus J, FRCR, Srihari, Narayanan, MD, Srinivasan, Rajaguru, FRCR, Staffurth, John, MD, Sundar, Santhanam, FRCR, Tolan, Shaun, MD, Tsang, David, MCRP, Wagstaff, John, Prof, Parmar, Mahesh K B, Prof

“…Summary Background Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled…”
Get full text

Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) by James, Nicholas David, Spears, Melissa R, Clarke, Noel W, Dearnaley, David P, De Bono, Johann S, Gale, Joanna, Hetherington, John, Hoskin, Peter J, Jones, Robert J, Laing, Robert, Lester, Jason F, McLaren, Duncan, Parker, Christopher C, Parmar, Mahesh K.B, Ritchie, Alastair W.S, Russell, J. Martin, Strebel, Räto T, Thalmann, George N, Mason, Malcolm D, Sydes, Matthew R

“…Abstract Background Prostate cancer (PCa) is the second most common disease among men worldwide. It is important to know survival outcomes and prognostic…”
Get full text

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma by Crabb, Simon J, Hussain, Syed, Soulis, Eileen, Hinsley, Samantha, Dempsey, Laura, Trevethan, Avril, Song, YeePei, Barber, Jim, Frew, John, Gale, Joanna, Faust, Guy, Brock, Susannah, McGovern, Ursula, Parikh, Omi, Enting, Deborah, Sundar, Santhanam, Ratnayake, Gihan, Lees, Kathryn, Birtle, Alison J, Powles, Thomas, Jones, Robert J

“…A DNA repair deficiency (DRD) phenotype exists within a subset of metastatic urothelial carcinomas (mUC) predicting benefit from platinum-based chemotherapy…”
Get full text

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial by Rush, Hannah L, Murphy, Laura, Morgans, Alicia K, Clarke, Noel W, Cook, Adrian D, Attard, Gerhardt, Macnair, Archie, Dearnaley, David P, Parker, Christopher C, Russell, J Martin, Gillessen, Silke, Matheson, David, Millman, Robin, Brawley, Christopher D, Pugh, Cheryl, Tanguay, Jacob S, Jones, Robert J, Wagstaff, John, Rudman, Sarah, O'Sullivan, Joe M, Gale, Joanna, Birtle, Alison, Protheroe, Andrew, Gray, Emma, Perna, Carla, Tolan, Shaun, McPhail, Neil, Malik, Zaf I, Vengalil, Salil, Fackrell, David, Hoskin, Peter, Sydes, Matthew R, Chowdhury, Simon, Gilbert, Duncan C, Parmar, Mahesh K B, James, Nicholas D, Langley, Ruth E

“…Docetaxel and abiraterone acetate plus prednisone or prednisolone (AAP) both improve survival when commenced alongside standard of care (SOC) androgen…”
Get full text

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial by Brown, Janet E, Royle, Kara-Louise, Gregory, Walter, Ralph, Christy, Maraveyas, Anthony, Din, Omar, Eisen, Timothy, Nathan, Paul, Powles, Tom, Griffiths, Richard, Jones, Robert, Vasudev, Naveen, Wheater, Matthew, Hamid, Abdel, Waddell, Tom, McMenemin, Rhona, Patel, Poulam, Larkin, James, Faust, Guy, Martin, Adam, Swain, Jayne, Bestall, Janine, McCabe, Christopher, Meads, David, Goh, Vicky, Min Wah, Tze, Brown, Julia, Hewison, Jenny, Selby, Peter, Collinson, Fiona, Carser, Judith, Srinivasan, Gopalakrishnan, Thistlewaite, Fiona, Azzabi, Ashraf, Beresford, Mark, Farrugia, David, Decatris, Marios, Thomas, Carys, Gale, Joanna, McAleer, James, Clayton, Alison, Boleti, Ekaterini, Geldart, Thomas, Sundar, Santhanam, Lester, Jason, Palaniappan, Nachi, Hingorani, Mohan, Rehman, Khaliq, Khan, Mohammad, Sarwar, Naveed, Graham, Janine, Thomson, Alastair, Srihari, Narayanan, Sheehan, Denise, Srinivasan, Rajaguru, Khan, Omar, Jane Worlding, Andrew Stockdale, Boussios, Stergios, Stuart, Nicholas, MacDonald-Smith, Carey, Danwata, Falalu, McLaren, Duncan, Sundaramurthy, Aravindhan, Lydon, Anna, Beesley, Sharon, Lees, Kathryn, Varughese, Mohini, Gray, Emma, Scott, Angela, Baxter, Mark, Mullard, Anna, Innominato, Pasquale, Kapur, Gaurav, Kumar, Anil, Charnley, Natalie, Manetta, Caroline, Chakraborti, Prabir, Das, Prantik, Rudman, Sarah, Taylor, Henry, Mikropoulos, Christos, Highley, Martin, Muthukumar, Dakshinamoorthy, Zarkar, Anjali, Vergis, Roy, Sriprasad, Seshadri, Brulinski, Patryk, Clarke, Amanda, Osbourne, Richard, Harvey, Melanie, Dega, Renata, Sparrow, Geoffrey, Barthakur, Urmila, Beaumont, Erica, Michael, Agnieszka, Porfiri, Emilio, Azam, Faisal, Kodavtiganti, Ravi

“…Temporary drug treatment cessation might alleviate toxicity without substantially compromising efficacy in patients with cancer. We aimed to determine if a…”
Get full text

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol by Attard, Gerhardt, Murphy, Laura, Sachdeva, Ashwin, Jones, Craig, Hoyle, Alex, Cross, William, Parker, Christopher C, Cook, Adrian, Gilson, Clare, Rush, Hannah, Abdel-Aty, Hoda, Amos, Claire L, Murphy, Claire, Chowdhury, Simon, Malik, Zafar, Parkar, Nazia, Pugh, Cheryl, Pezaro, Carmel, Grant, Warren, Saxby, Helen, Birtle, Alison, Thomas, Carys, Tanguay, Jacob, Parikh, Omi, Cathomas, Richard, Brown, Michael D, Jain, Yatin, Dearnaley, David P, Mason, Malcolm D, Millman, Robin, Sydes, Matthew R, Parmar, Mahesh K B, James, Nicholas D, Hyde, Katherine, Glen, Hilary, McGovern, Ursula, Beresford, Mark, Malik, Zafar, Lee, Ling, Sreenivasan, Thiagarajan, Brock, Sue, Brown, Simon, Smith-Howell, Mike, Phan, Mau-Don, Narahari, Krishna, Tanguay, Jacob, Douglas, Fiona, Kumar, Anil, Simms, Matthew, Worlding, Jane, Tran, Anna, Pezaro, Carmel, Sivoglo, Virgil, Masters, Benjamin, Manetta, Caroline, McLaren, Duncan, Taylor, Henry, Perna, Carla, Melcher, Lucinda, Grant, Warren, Dealey, Robert, McPhail, Neil, Brierly, Robert, Sidek, Norma, Whelan, Peter, Robson, Peter, Falconer, Alison, Rudman, Sarah, Vivekanandan, Sindu, Mullessey, Vinod, Vilarino-Varela, Maria, Khoo, Vincent, Sangar, Vijay, Hoskin, Peter, Mullassery, Viwod, Sundar, Santhanam, Khan, Yakhub, Conroy, Ruth, Carser, Judith, Rogers, Paul, Tarver, Kathryn, Gibbs, Stephanie, Khan, Mohammad Muneeb, Hingorani, Mohan, Alameddine, Manal, Hughes, Robert, Logue, John, Vengalil, Salil, Khan, Omar, Ahmed, Imtiaz, Nikapota, Ashok, Bloomfield, David, Rentsch, Cyrill, Pereira Mestre, Ricardo, Roggero, Enrico, Borner, Markus, Berthold, Dominik, Engeler, Daniel, John, Hubert, Popescu, Razvan

“…Abiraterone acetate plus prednisolone (herein referred to as abiraterone) or enzalutamide added at the start of androgen deprivation therapy improves outcomes…”
Get full text

Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial by Rescigno, Pasquale, Porta, Nuria, Finneran, Laura, Riisnaes, Ruth, Figueiredo, Ines, Carreira, Suzanne, Flohr, Penny, Miranda, Susana, Bertan, Claudia, Ferreira, Ana, Crespo, Mateus, Rodrigues, Daniel Nava, Gurel, Bora, Nobes, Jenny, Crabb, Simon, Malik, Zafar, Ralph, Christy, McGovern, Ursula, Hoskin, Peter, Jones, Robert J., Birtle, Alison, Gale, Joanna, Sankey, Peter, Jain, Suneil, McLaren, Duncan, Chadwick, Eliot, Espinasse, Aude, Hall, Emma, de Bono, Johann

“…PTEN loss and aberrations in PI3K/AKT signaling kinases associate with poorer response to abiraterone acetate (AA) in metastatic castration-resistant prostate…”
Get full text

Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476) by James, Nicholas D., Clarke, Noel W., Cook, Adrian, Ali, Adnan, Hoyle, Alex P., Attard, Gerhardt, Brawley, Christopher D., Chowdhury, Simon, Cross, William R., Dearnaley, David P., Bono, Johann S., Diaz‐Montana, Carlos, Gilbert, Duncan, Gillessen, Silke, Gilson, Clare, Jones, Rob J., Langley, Ruth E., Malik, Zafar I., Matheson, David J., Millman, Robin, Parker, Chris C., Pugh, Cheryl, Rush, Hannah, Russell, J. Martin, Berthold, Dominik R., Buckner, Michelle L., Mason, Malcolm D., Ritchie, Alastair W. S., Birtle, Alison J., Brock, Susannah J., Das, Prantik, Ford, Dan, Gale, Joanna, Grant, Warren, Gray, Emma K., Hoskin, Peter, Khan, Mohammad M., Manetta, Caroline, McPhail, Neil J., O'Sullivan, Joe M., Parikh, Omi, Perna, Carla, Pezaro, Carmel J., Protheroe, Andrew S., Robinson, Angus J., Rudman, Sarah M., Sheehan, Denise J., Srihari, Narayanan N., Syndikus, Isabel, Tanguay, Jacob S., Thomas, Carys W., Vengalil, Salil, Wagstaff, John, Wylie, James P., Parmar, Mahesh K. B., Sydes, Matthew R.

“…Abiraterone acetate plus prednisolone (AAP) previously demonstrated improved survival in STAMPEDE, a multiarm, multistage platform trial in men starting…”
Get full text

A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm by Crabb, Simon J., Hussain, Syed A., Soulis, Eileen, Hinsley, Samantha, Dempsey, Laura, Trevethan, Avril, Song, Yee Pei, Barber, Jim, Frew, John A., Gale, Joanna, Faust, Guy, Brock, Susannah Joy, McGovern, Ursula Brigid, Parikh, Omi, Enting, Deborah, Sundar, Santhanam, Ratnayake, Gihan, Lees, Kathryn, Powles, Thomas, Jones, Robert J.

“…Abstract only 436 Background: A subset of mUC exhibits a DNA repair deficiency (DRD) phenotype predicting benefit from platinum based chemotherapy (PBC). We…”
Get full text

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial by Chris C Parker, Nicholas D James, Christopher D Brawley, Noel W Clarke, Adnan Ali, Claire L Amos, Gerhardt Attard, Simon Chowdhury, Adrian Cook, William Cross, David P Dearnaley, Hassan Douis, Duncan C Gilbert, Clare Gilson, Silke Gillessen, Alex Hoyle, Rob J Jones, Ruth E Langley, Zafar I Malik, Malcolm D Mason, David Matheson, Robin Millman, Mary Rauchenberger, Hannah Rush, J Martin Russell, Hannah Sweeney, Amit Bahl, Alison Birtle, Lisa Capaldi, Omar Din, Daniel Ford, Joanna Gale, Ann Henry, Peter Hoskin, Mohammed Kagzi, Anna Lydon, Joe M O'Sullivan, Sangeeta A Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Nair Srihari, Jacob Tanguay, Mahesh K B Parmar, Matthew R Sydes, STAMPEDE Trial Collaborative Group

“…BackgroundSTAMPEDE has previously reported that radiotherapy (RT) to the prostate improved overall survival (OS) for patients with newly diagnosed prostate…”
Get full text

Pathological and Clinical Analysis of Vascular Catheterization Models in Rats, with Exploration of Interventions to Improve Clinical Tolerance by Allavena, Rachel E., West, Heather, Gale, Joanna, Debrue, Marie

“…Permanent vascular catheterization for intravascular access is one of the most commonly applied techniques used on rodents in pharmacology studies. However,…”
Get full text

Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476) by James, Nicholas D., De Bono, Johann S., Spears, Melissa Ruth, Clarke, Noel, Mason, Malcolm David, Dearnaley, David P., Ritchie, Alastair W S, Russell, J. Martin, Gilson, Clare, Jones, Robert J., Gillessen, Silke, Matheson, David, Aung, San, Birtle, Alison J., Chowdhury, Simon, Gale, Joanna, Malik, Zafar, O'Sullivan, Joe M., Parmar, Mahesh K B, Sydes, Matthew Robert

“…Abstract only LBA5003 Background: Abiraterone showed a survival advantage in men with castration-refractory prostate cancer. We assessed whether abiraterone…”
Get full text

Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476) by James, Nicholas D., De Bono, Johann S., Spears, Melissa Ruth, Clarke, Noel, Mason, Malcolm David, Dearnaley, David P., Ritchie, Alastair W S, Russell, J. Martin, Gilson, Clare, Jones, Robert J., Gillessen, Silke, Matheson, David, Aung, San, Birtle, Alison J., Chowdhury, Simon, Gale, Joanna, Malik, Zafar, O'Sullivan, Joe M., Parmar, Mahesh K B, Sydes, Matthew Robert

“…Abstract only LBA5003 The full, final text of this abstract will be available at abstracts.asco.org at 7:30 AM (EDT) on Saturday, June 3, 2017, and in the…”
Get full text

Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure by GELDART, THOMAS R., GALE, JOANNA, McKENDRICK, JOE, KIRBY, JULIE, MEAD, GRAHAM

“…OBJECTIVE To identify patients with late relapse of metastatic, nonseminomatous germ cell tumour (NSGCT) and to evaluate the patterns of relapse, treatment and…”
Get full text